ज़ल्टोफी 100iu/3.6एमजी इंजेक्शन के लिए 3एमएल सॉल्यूशन का प्री-फिल्ड पेन
प्री-फ्लुए पेन में इंजेक्शन के लिए 3एमएल सॉल्यूशनMRP ₹5376.94
₹4496.78
16% OFF
निर्मित
नोवो नॉर्डिस्क इंडिया प्राइवेट लिमिटेड
डोजेज
SOLUTION FOR INJECTION
समाप्ति
प्रोडक्ट का सारांश
| शामिल है | इंसुलिन डेग्लूडेक(100.0 आईयू/एमएल) + लिराग्लूटाइड (3.6 एमजी/एमएल |
| थेरेपी | Anti-diabetic |
जांच
द्वारा निर्धारित
Medical Description
Xultophy Injection is a medication used for adults with type 2 diabetes who need better blood sugar control, even with diet, exercise, and other diabetes medicines. It is administered once daily, subcutaneously, in the thigh, upper arm, or abdomen, with or without food. Use it at the same time each day and rotate injection sites to prevent skin problems, such as thickening or pits.
Xultophy Injection combines two active ingredients. Insulin degludec is a long-acting insulin that provides steady insulin levels throughout the day and night, helping to lower blood sugar levels between meals and during sleep. Liraglutide helps your body release the right amount of insulin when needed, slows the rate at which food leaves your stomach, and lowers the amount of sugar produced by your liver. This helps keep your blood sugar levels more balanced, especially after eating.
Some common side effects include low blood sugar, nausea, vomiting, diarrhoea, constipation, dizziness, and stomach discomfort. You may also feel full quickly or have a reduced appetite. It is essential to recognise the symptoms of low blood sugar, including sweating, confusion, or feeling shaky. If these occur, notify your doctor immediately.
Certain medicines may interact with Xultophy Injection, including other diabetes drugs, blood pressure medicines, steroids, thyroid hormones, and birth control pills. Alcohol can also affect how this medicine works, so it is best to avoid drinking. If you are taking other medications or have underlying health conditions, please inform your doctor so they can adjust your treatment as necessary.
Store your Xultophy Injection in the refrigerator before opening. After opening, keep it at room temperature (below 30°C) or in the refrigerator. Always keep the pen cap on to prevent the pen from drying out or freezing. Let your doctor know if you are pregnant, planning to become pregnant, or breastfeeding, as this medicine is not recommended in those situations.
Uses
Contraindications
Side effects
- Hypoglycaemia
- Nausea
- Diarrhoea
- Vomiting
- Constipation
- Dyspepsia
- Gastritis
- Abdominal pain
- Gastroesophageal reflux disease
- Abdominal distension
- Loss of appetite
- Dizziness
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have type 1 diabetes, diabetic ketoacidosis, or severe heart failure, as Xultophy Injection is not suitable in these conditions.
- You may notice signs of low or high blood sugar, such as sweating, confusion, thirst, or frequent urination.
- You have stomach pain, vision changes, thyroid issues, or a history of pancreatitis.
- You have conditions like heart problems, frequent dehydration, or are planning surgery or deep sedation, as Xultophy Injection may increase the risk of complications in these situations.
Directions for Use
- Xultophy Injection is injected under the skin (subcutaneously) of your thigh, upper arm or stomach (abdomen).
- Use it at the same time each day with or without food.
- Change (rotate) your injection site with each injection to help reduce your chances of getting skin thickening or pits at the injection site. Do not use the same site for each injection.
Storage and disposal
- Before first opening: Store in a refrigerator (2 °C – 8 °C). Keep away from the freezing element. Do not freeze. Keep the cap on the pre-filled pen in order to protect it from light.
- After first opening: Store at a maximum of 30 °C or store in a refrigerator (2 °C – 8 °C). Do not freeze. Keep the cap on the pre-filled pen in order to protect it from light.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
- Insulin degludec is a long-acting insulin that helps lower blood sugar levels in people with diabetes. After you inject it, it slowly releases into your body over time, providing a steady level of insulin throughout the day and night. This helps your body use sugar more effectively and prevents your blood sugar levels from becoming too high, especially between meals and during periods of rest.
- Liraglutide works by helping your body release the right amount of insulin when your blood sugar is high. It also lowers the amount of sugar made by your liver and slows down how quickly food leaves your stomach, which helps you feel full longer. This helps keep your blood sugar levels more stable, especially after meals.
Interactions
Interactions with other medicines
- Some medicines may increase or decrease the amount of Xultophy Injection you need, such as other diabetes medications, blood pressure medications, steroids, thyroid hormones, and birth control pills.
- Alcohol can affect how this medication works and may increase the risk of low blood sugar.
- Beta-blockers can hide signs of low blood sugar, such as a fast heartbeat.
- Medicines such as octreotide, lanreotide, and warfarin may require additional monitoring or dose adjustments when taken with this medication.
- Xultophy Injection may slightly slow the absorption of certain oral medicines, but this usually does not affect their overall effect or require dose adjustments.
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
क्या आपको यह उपयोगी लगा?
Explore More at Pharmeasy
निर्माता विवरण
Brand:जुलटॉफी
Manufacturer Name:नोवो नॉर्डिस्क इंडिया प्राइवेट लिमिटेड
Address:नोवो नॉर्डिस्क ए/एस नोवो अली डीके 2880 बैग्सवार्ड डेनमार्क
Country of Origin:डेनमार्क
विक्रेता विवरण
ऑर्डर पूर्ति की जानकारी: Xultophy 100iu/3.6mg Pre Filled Pen Of 3ml Solution For Injection will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- U.S. Summary of Product Characteristics. Xultophy 100 units/mL + 3.6 mg/mL solution for injection [Internet]. Kent, UK: Novo Nordisk Limited; 2024 Nov 15 [cited 2025 Jun 25].
- Central Drugs Standard Control Organisation. Drugs [Internet]. New Delhi: Ministry of Health and Family Welfare, Government of India; [cited 2025 Jun 25].
किसी भी समस्या की स्थिति में हमसे संपर्क करें
ईमेल आईडी:care@pharmeasy.in
फोन नंबर:7666100300
पता:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
अस्वीकरण / खंडन
यहां प्रदान की गई जानकारी हमारी सर्वोत्तम क्षमताओं के अनुसार है और इसे यथार्थ और विश्वसनीय बनाने के लिए पेशेवरों की एक टीम द्वारा समीक्षा के बाद प्रकाशित किया जाता है। यह जानकारी पूरी तरह से उत्पाद पर एक सामान्य अवलोकन प्रदान करने के लिए है और इसका उपयोग केवल सूचनात्मक उद्देश्यों के लिए किया जाना चाहिए। आपको यहां दी गई जानकारी का उपयोग किसी स्वास्थ्य समस्या के निदान, रोकथाम या इलाज के लिए नहीं करना चाहिए। इस साइट पर मौजूद किसी भी चीज़ का उद्देश्य किसी डाक्टर के चिकित्सा उपचार/सलाह या परामर्श को बदलना या प्रतिस्थापित करना नहीं है। किसी भी दवा के बारे में किसी भी जानकारी या चेतावनी की अनुपस्थिति को एक निहित आश्वासन के रूप में नहीं माना जाएगा। हम अत्यधिक अनुशंसा करते हैं कि आप अपनी चिकित्सा स्थिति से संबंधित सभी प्रश्नों या संदेहों के लिए अपने डाक्टर से परामर्श लें। आप इस बात से सहमत हैं कि आप यह साइट में मौजूद किसी भी चीज़ के आधार पर संपूर्ण या आंशिक रूप से स्वास्थ्य या चिकित्सा संबंधी कोई निर्णय नहीं लेंगे। कृपया विस्तृत नियम एवं शर्तों के लिए यहां क्लिक करें।
